CaMKIV limits metabolic damage through induction of hepatic autophagy by CREB in obese mice.
High-fat diet (HFD) not only induces insulin resistance in liver, but also causes autophagic imbalance, metabolic disorders, increases chronic inflammatory response and induces mitochondrial dysfunction. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) has recently emerged as an important regulator of glucose metabolism and skeletal muscle insulin action. Its activation has been involved in the improvement of hepatic and adipose insulin action. But the underlying mechanism are not fully understood. In the present study, we aimed to address the direct effects of CaMKIV in vivo and to evaluate the potential interaction of impaired insulin sensitivity and autophagic disorders in hepatic insulin resistance. Our results indicated obese mice receiving CaMKIV showed a decreased blood glucose and serum insulin, and improved insulin sensitivity as well as increased glucose tolerance compared with vehicle injection. Meanwhile, defective hepatic autophagy activity, impaired insulin signaling, increased inflammatory response and mitochondrial dysfunction in liver tissues which induced by high-fat diet were also effectively alleviated by injection of CaMKIV. Consistent with these results, the additional of CaMKIV to the culture medium of BNL cl.2 hepatocytes markedly restored palmitate induced hepatic insulin resistance and autophagic imbalance. These effects were nullified by blockade of cyclic AMP response element binding protein (CREB), indicating the causative role of CREB in action of CaMKIV. Our findings suggested that CaMKIV restores hepatic autophagic imbalance and improves impaired insulin sensitivity via phosphorylated CREB signaling pathway. Which may offer novel opportunities for treatment of obesity and diabetes.